About Holmusk
Holmusk is a company based in Singapore (Singapore) founded in 2015 by Nawal Roy was acquired by Twitter in July 2022. Holmusk has raised $109.29 million across 7 funding rounds from investors including Northwell, Veradigm and Heritas Capital Management. Holmusk has completed 1 acquisition, including MindLinc. Holmusk offers products and services including NeuroBlu Database, NeuroBlu Analytics, and Care Management Software. Holmusk operates in a competitive market with competitors including Neurosity, PREDICTIX, Televero Health, ThinkQuality and Mimerse, among others.
- Headquarter Singapore, Singapore
- Founders Nawal Roy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kkt Technology Pte. Ltd.
-
Annual Revenue
$1.66 M (USD)73as on Mar 31, 2020
-
Net Profit
-$2.8 M (USD)7as on Mar 31, 2020
-
EBITDA
-$2.43 M (USD)7as on Mar 31, 2020
-
Total Equity Funding
$109.29 M (USD)
in 7 rounds
-
Latest Funding Round
$30 M (USD), Series B
Oct 12, 2023
-
Investors
Northwell
& 6 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Twitter
(Jul 12, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Holmusk
Holmusk offers a comprehensive portfolio of products and services, including NeuroBlu Database, NeuroBlu Analytics, and Care Management Software.
Offers real-world data for behavioral health studies and research.
Provides tools for data analysis and cohort building in health research.
Utilizes data to enhance care operations and reduce costs effectively.
People of Holmusk
Unlock access to complete
Unlock access to complete
Funding Insights of Holmusk
Holmusk has successfully raised a total of $109.29M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Holmusk
Holmusk has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Northwell, Veradigm and Heritas Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital investment firm
|
Locked | Locked | Locked | |
|
Growth-stage US tech companies are funded by Health Catalyst Capital.
|
Locked | Locked | Locked | |
|
Early-stage investments in US Tech and Life Sciences are targeted.
|
Locked | Locked | Locked |
Investor details for Holmusk
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Holmusk
Holmusk has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MindLinc.
Investment portfolio details for Holmusk
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
EMR platform and global database for behavioral health are offered.
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Holmusk
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Holmusk
Detailed financials for Holmusk
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Holmusk Comparisons
Peer comparison for Holmusk
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Holmusk
Holmusk operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neurosity, PREDICTIX, Televero Health, ThinkQuality and Mimerse, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of neural devices and apps for mental health diagnosis and medical intervention
|
|
| Locked | Locked | Locked |
Provider of AI-based mental health decision support platform
|
|
| Locked | Locked | Locked |
Cloud-based behavioral health therapy solution for providers
|
|
| Locked | Locked | Locked |
Clinical data intelligence is delivered with behavioral analysis for healthcare.
|
|
| Locked | Locked | Locked |
Develops innovative virtual reality applications for mental health treatments.
|
Detailed competitors of Holmusk
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Holmusk
Complete news archive for Holmusk
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Holmusk
Holmusk was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Holmusk is headquartered in Singapore, Singapore.
Nawal Roy is the current CEO of Holmusk. They have also founded this company.
Holmusk is a funded company, having raised a total of $109.29M across 7 funding rounds to date.
Annual revenue of Holmusk is $1.66M as on Mar 31, 2020.
AI-based digital health solutions and data analytics for providers. The platform NeuroBlu monitors the users data and the prediction engine recommends lifestyle changes before the condition worsens. The proprietary analytical tools work on real-world data to recognize disease progression. The EHR system is designed to capture and monitor decisions and is combined with past mental health records. It also enables data-driven research and development providing evidence for regulatory submission.
Holmusk's top competitors include Televero Health, Doctorpresso and Neurosity.
Holmusk offers NeuroBlu Database, NeuroBlu Analytics, and Care Management Software.
Holmusk has made 1 acquisition, including MindLinc.
Holmusk has 7 investors. Key investors include Northwell, Veradigm, Heritas Capital Management, Health Catalyst Capital, and dRx Capital.